The efficacy and safety of anticoagulant therapy Arixtra Injection for the prevention of the vein thromboembolism in laparoscopic colorectal surgery

The efficacy and safety of anticoagulant therapy Arixtra Injection for the prevention of the vein thromboembolism in laparoscopic colorectal surgery - The efficacy and safety of anticoagulant therapy Arixtra Injection for the prevention of the vein thromboembolism in laparoscopic colorectal surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007005

Enrollment

200

Registered

2012-01-10

Start date

2012-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

Fondaparinux none

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients underwent laparocopic surgery for colorectal cancer

Exclusion criteria

Exclusion criteria: patients who are thout to be inapropreate for this study

Design outcomes

Primary

Measure	Time frame
The efficacy of the incidence of venous thromboembolism. The safety of the incidence of Major bleeding	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026